Bioventus to Present at the Canaccord Genuity 44th Annual Global Growth Conference
Bioventus Inc. (Nasdaq: BVS), a global leader in active healing innovations, has announced its participation in the Canaccord Genuity 44th Annual Global Growth Conference. Mark Singleton, the company's senior vice president and chief financial officer, will engage in a fireside chat on Wednesday, August 14, 2024, at 9:00 a.m. ET.
The event will feature a live webcast of the presentation, followed by a question-and-answer session. Interested parties can access the webcast through the 'Investors' section of Bioventus' website at www.bioventus.com. The presentation will also be available for replay on the site after the event concludes, providing an opportunity for those unable to attend live to catch up on the company's insights and updates.
Bioventus Inc. (Nasdaq: BVS), un leader globale nelle innovazioni per la guarigione attiva, ha annunciato la sua partecipazione alla 44a Conferenza Annuale sul Crescita Globale di Canaccord Genuity. Mark Singleton, vicepresidente senior e direttore finanziario dell'azienda, parteciperà a una chiacchierata informale mercoledì 14 agosto 2024, alle 9:00 ET.
L'evento includerà un webcast in diretta della presentazione, seguito da una sessione di domande e risposte. Le parti interessate possono accedere al webcast tramite la sezione 'Investitori' del sito web di Bioventus all'indirizzo www.bioventus.com. La presentazione sarà disponibile anche per la riproduzione sul sito dopo la conclusione dell'evento, offrendo un'opportunità a coloro che non possono partecipare in diretta di recuperare le informazioni e gli aggiornamenti dell'azienda.
Bioventus Inc. (Nasdaq: BVS), un líder global en innovaciones de curación activa, ha anunciado su participación en la 44ª Conferencia Anual sobre Crecimiento Global de Canaccord Genuity. Mark Singleton, vicepresidente senior y director financiero de la compañía, participará en una charla informal el miércoles 14 de agosto de 2024, a las 9:00 a.m. ET.
El evento contará con una transmisión en vivo de la presentación, seguida de una sesión de preguntas y respuestas. Las partes interesadas pueden acceder a la transmisión a través de la sección 'Inversores' del sitio web de Bioventus en www.bioventus.com. La presentación también estará disponible para su reproducción en el sitio después de que concluya el evento, brindando una oportunidad para aquellos que no puedan asistir en vivo de ponerse al día con las perspectivas y actualizaciones de la empresa.
Bioventus Inc. (Nasdaq: BVS), 글로벌 활성 치유 혁신의 선두주자는 Canaccord Genuity 제44회 연례 글로벌 성장 컨퍼런스에 참여한다고 발표했습니다. 회사의 선임 부사장 겸 CFO인 Mark Singleton이 2024년 8월 14일 수요일 오전 9:00 ET에 파이어사이드 챗에 참여합니다.
이번 행사에서는 프레젠테이션의 실시간 웹캐스트가 진행되며, 이어서 질문 및 답변 시간이 마련됩니다. 관심 있는 분들은 www.bioventus.com의 Bioventus '투자자' 섹션을 통해 웹캐스트에 접속할 수 있습니다. 행사 종료 후 회사를 놓친 분들을 위해 사이트에서 프레젠테이션을 다시 볼 수 있는 기회도 제공됩니다.
Bioventus Inc. (Nasdaq: BVS), un leader mondial dans les innovations de guérison active, a annoncé sa participation à la 44e Conférence Annuelle sur la Croissance Mondiale de Canaccord Genuity. Mark Singleton, vice-président senior et directeur financier de l'entreprise, participera à une discussion informelle le mercredi 14 août 2024 à 9h00 ET.
L'événement comprendra un webinaire en direct de la présentation, suivi d'une session de questions-réponses. Les personnes intéressées peuvent accéder au webinaire via la section 'Investisseurs' du site web de Bioventus à l'adresse www.bioventus.com. La présentation sera également disponible en replay sur le site après la fin de l'événement, offrant ainsi une occasion à ceux qui ne peuvent pas assister en direct de se rattraper sur les perspectives et les mises à jour de l'entreprise.
Bioventus Inc. (Nasdaq: BVS), ein globaler führer in aktiven Heilinnovationen, hat seine Teilnahme an der 44. jährlichen Global Growth Conference von Canaccord Genuity angekündigt. Mark Singleton, der Senior Vice President und Chief Financial Officer des Unternehmens, wird am Mittwoch, den 14. August 2024, um 9:00 Uhr Eastern Time an einem Fireside-Chat teilnehmen.
Die Veranstaltung umfasst einen Live-Webcast der Präsentation, gefolgt von einer Fragerunde. Interessierte können über den 'Investoren'-Bereich der Bioventus-Website unter www.bioventus.com auf den Webcast zugreifen. Die Präsentation wird auch nach Abschluss der Veranstaltung auf der Website zur Verfügung stehen, sodass diejenigen, die nicht live teilnehmen können, die Einblicke und Updates des Unternehmens nachholen können.
- None.
- None.
DURHAM, N.C., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Mark Singleton, senior vice president and chief financial officer, will participate in a fireside chat at the Canaccord Genuity Global Growth Conference on Wednesday, August 14, 2024, at 9:00 a.m. ET.
A live webcast of the presentation, followed by a question-and-answer session will be available on the “Investors” section of the Company’s website at www.bioventus.com and will be available for replay on that site following the event.
About Bioventus
Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations for Active Healing from Bioventus include offerings for Pain Treatments, Restorative Therapies and Surgical Solutions. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, visit www.bioventus.com, and follow the Company on LinkedIn and Twitter. Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.
Investor and Media Contact:
Dave Crawford
919-474-6787
dave.crawford@bioventus.com
FAQ
When is Bioventus (BVS) presenting at the Canaccord Genuity Global Growth Conference?
Who will be representing Bioventus (BVS) at the Canaccord Genuity conference?
How can I watch Bioventus' (BVS) presentation at the Canaccord Genuity conference?
What type of event will Bioventus (BVS) participate in at the Canaccord Genuity conference?
